CD8A and ovarian carcinoma: IL-12 expressing oncolytic herpes simplex virus was shown to promote eradication of both murine and human ovarian cancer cell lines and promote TAA-specific CD8+ T-cell responses in the peritoneal cavity and omentum, leading to reduced peritoneal metastasis and improved survival in the mouse model tgMISIIRTAg [107].